Puavilai Siripen, Noppakun Nopadon, Sitakalin Chasuree, Leenutaphong Vichit, Wattanakrai Penpun, Nakakes Artit, Kulthanan Kanokvalai, Asawanonda Pravit, Akaraphan Ratsanee, Tresukosol Poohglin, Suthipinittharm Puan, Somburanasin Pitchaya, Charuwichitratana Somyos, Rajatanavin Natta
Division of Dermatology, Department of Medicine, Ramathibodi Hospital Medical School, Mahidol University, Bangkok 10400, Thailand.
J Med Assoc Thai. 2005 Nov;88(11):1642-50.
The study was performed in five hospitals in Bangkok for a period of one year. All in- and outpatients who developed drug eruption from January to December 2001 were enrolled into the study. Physical examinations and complete history-taking were performed by one of the authors. A skin biopsy was done to confirm the diagnosis in every suspected case. Oral challenge test was performed to obtain a definite diagnosis only in some patients with informed consent. Among 212 patients, the most common causative drugs were antimicrobial agents with cephalosporin group in the highest rank. Maculopapular rash was the most common type of drug eruption followed by urticaria and photosensitivity reaction. It was concluded that antimicrobial agents were the predominant causative agents and maculopapular eruption was the most frequent clinical manifestation. New kinds of antimicrobial agents, anti-inflammatory drugs and lipid lowering agents could cause various patterns of drug eruption.
该研究在曼谷的五家医院进行,为期一年。纳入了2001年1月至12月期间出现药物疹的所有住院和门诊患者。由其中一位作者进行体格检查并完成病史采集。对每例疑似病例均进行皮肤活检以确诊。仅对部分获得知情同意的患者进行口服激发试验以明确诊断。在212例患者中,最常见的致病药物是抗菌药物,其中头孢菌素类位居首位。斑丘疹是最常见的药物疹类型,其次是荨麻疹和光敏反应。得出的结论是,抗菌药物是主要的致病因素,斑丘疹是最常见的临床表现。新型抗菌药物、抗炎药物和降脂药物可引起各种类型的药物疹。